
Registration is complimentary and required to attend.
About this webinar:
Biotech CMOs have worked predominantly towards securing R&D milestones and regulatory approval. As we know, market access and policy considerations increasingly define commercial success and funding potential at earlier stages of development. A strong understanding of the interconnectedness of these systems enables CMOs to better position their clinical strategy and advocate to improve patient access to new therapeutics.
In this webcast, leaders from pharma, biotech and VC discuss the interplay between R&D investment, public policy, and patient access to new therapeutics.
More specifically:
- An novel measurement and analysis of R&D investments and intensity across the biopharma ecosystem
- The impact public policy has on R&D decision making, innovation, financing and market access
- Specific ways biotech CMOs and clinical and medical affairs leaders can advocate on policy and patient access issues
This webinar is brought to you by the CMO Summit 360°®:
Registration is complimentary and required to attend.